On-Demand Upstream Manufacturing Webinars
-
How Intensified Upstream Processing Improves Scale-Up And Tech Transfer
6/22/2026
Intensified upstream processing can improve scalability and maintain quality. Learn how automation, PAT, and data-driven control strategies help modernize workflows and support consistent performance.
-
Generate Stable High-Producing Clones In 14 Weeks
6/18/2026
Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.
-
Enabling Clinical-Grade Automated Manufacturing Of γδ T Cells
6/12/2026
Explore smarter approaches to γδ T cell manufacturing, including scalable expansion, efficient transduction, and streamlined analytics, as well as how to build workflows that support validation.
-
Establishing The First Chinese Haplobank Of Clinical-Grade hiPSCs
6/11/2026
Learn how automated, closed workflows and GMP-ready infrastructure are advancing pluripotent stem cell development from scalable expansion and differentiation to building regional capacity.
-
Achieving Clinical Quality For Human iPSC Generation And Expansion
6/11/2026
Gain practical insight into building scalable stem cell manufacturing processes while maintaining consistency and quality across workflows, as well as in-depth guidance to support your strategy.
-
Automated GMP-Compliant PSC Banking In A Closed System
6/11/2026
Explore advances in automated adherent cell culture and the optimization of large-scale iPSC expansion, as well as how standardization and process control are improving reproducibility.
-
Manufacturing GMP-Compliant iPSCs In Closed And Open Systems
6/11/2026
Gain practical insight into scaling human iPSC manufacturing with expert perspectives on process control, reproducibility, and automated workflows designed to support stem cell expansion.
-
Advancing Clinical-Grade TIL Therapy Manufacturing
6/11/2026
TIL therapy continues to advance, but manufacturing complexity limits its potential. See how automated workflows for generating tumor-reactive T cells can improve consistency, scalability, and readiness.
-
Automated And Streamlined Manufacturing Of TIL Therapies
6/11/2026
Advances in TIL therapy are driving a shift from manual processes to streamlined, automated manufacturing. Discover how improved workflows and early clinical results are shaping cancer treatments.
-
Comprehensive Bioprocess Control: Substrate, Metabolite And Product Analysis
5/6/2026
Explore how multi-parameter bioprocess analyzers support monitoring of 30+ bioprocess parameters across mammalian and microbial systems to optimize yield and product quality.